-
Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 05 Oct 2024 03:29:10 America/Chicago
Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Immunovant, Inc. ( NASDAQ:IMVT - Get Free Report ) have been assigned an average reco
Read more...